Lv1
50 积分 2026-01-09 加入
Understanding the therapeutic toolkit for inflammatory bowel disease
1个月前
已完结
AI-enabled ‘endo-histo-omics’: breaking down intestinal barriers in IBD
1个月前
已完结
Developing an adaptive platform trial for evaluation of medical treatments for Crohn’s disease
1个月前
已完结
Influence of biological sex in inflammatory bowel diseases
1个月前
已完结
Increased inflammatory responsiveness of peripheral blood mononuclear cells (PBMCs) to in vitro NOD2 ligand stimulation in patients with ankylosing spondylitis
1个月前
已完结
Repurposing of clinical-stage FLT3 inhibitor HYML-122 as a potent RIPK2 inhibitor for the treatment of inflammatory bowel disease
5个月前
已完结
Serum Extracellular Matrix Molecules and Their Fragments as Biomarkers of Inflammation and Fibrosis in Inflammatory Bowel Diseases: A Systematic Review
6个月前
已完结
Preclinical Translational Physiologically Based Pharmacokinetic Modeling for Predicting Human Pharmacokinetics of PROTACs: Case Studies of Vepdegestrant (ARV-471) and Bavdegalutamide (ARV-110)
8个月前
已完结
Pharmacodynamic Models of Indirect Effects and Irreversible Inactivation with Turnover: Applicability to Mechanism-Based Modeling of Gene Silencing and Targeted Protein Degradation
9个月前
已完结
Correlation Between Serum and Fecal Biomarkers and Patient-Reported Outcomes in Patients with Crohn’s Disease and Ulcerative Colitis
9个月前
已完结
皖公网安备34019202002308
